Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patient

Ann Hematol. 2013 Jul;92(7):1001-2. doi: 10.1007/s00277-012-1659-z. Epub 2012 Dec 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • HIV Infections / blood
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Hepatitis C / blood
  • Hepatitis C / complications*
  • Hepatitis C / drug therapy
  • Humans
  • Interferon-alpha / therapeutic use
  • Male
  • Platelet Count
  • Polyethylene Glycols / therapeutic use
  • Receptors, Fc / therapeutic use*
  • Receptors, Thrombopoietin / agonists*
  • Recombinant Fusion Proteins / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Ribavirin / therapeutic use
  • Thrombocytopenia / blood
  • Thrombocytopenia / drug therapy*
  • Thrombocytopenia / etiology
  • Thrombopoietin / therapeutic use*

Substances

  • Anti-HIV Agents
  • Antiviral Agents
  • Interferon-alpha
  • Receptors, Fc
  • Receptors, Thrombopoietin
  • Recombinant Fusion Proteins
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • Thrombopoietin
  • romiplostim
  • peginterferon alfa-2a